Coherent Corp.: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 6, 2024 and accepted by EDGAR at Feb 6, 2024, 07:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $1.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-07-01 to 2023-12-31 | $2.18bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-10-01 to 2023-12-31 | $780.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-07-01 to 2023-12-31 | $1.53bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2023-10-01 to 2023-12-31 | $111.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-07-01 to 2023-12-31 | $224.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-10-01 to 2023-12-31 | $209.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-07-01 to 2023-12-31 | $420.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | $31.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-01 to 2023-12-31 | $10.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $74.7m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-07-01 to 2023-12-31 | $147.9m | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | −$8.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-07-01 to 2023-12-31 | −$29.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | −$27.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-07-01 to 2023-12-31 | −$94.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | −$0.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-01 to 2023-12-31 | −$1.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | −$0.38 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-01 to 2023-12-31 | −$1.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 151,564,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-01 to 2023-12-31 | 150,946,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-01 to 2023-12-31 | $266.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-07-01 to 2023-12-31 | $153.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-12-31 | $856.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $3.42bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $14.66bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $1.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $6.52bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $4.14bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $74.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-12-31 | $5.47bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000820318-24-000004. Last ingested by Listed: Nov 5, 2026, 13:54 ET. Listed shows no prices and gives no investment advice.